Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Examining the impact of data quality and completeness of electronic health records on predictions of patients' risks of cardiovascular disease.

Li Y, Sperrin M, Martin GP, Ashcroft DM, van Staa TP.

Int J Med Inform. 2020 Jan;133:104033. doi: 10.1016/j.ijmedinf.2019.104033. Epub 2019 Nov 11.

PMID:
31785526
2.

Psoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease Risk.

Kleyn CE, Talbot PS, Mehta NN, Sampogna F, Bundy C, Ashcroft DM, Kimball AB, Kerkhof PCM, Griffiths CEM, Valenzuela F, van der Walt JM, Aberra T, Puig L.

Acta Derm Venereol. 2019 Nov 19. doi: 10.2340/00015555-3375. [Epub ahead of print]

3.

Temporal trends in incidence of hospital-treated self-harm among adolescents in Denmark: national register-based study.

Steeg S, Carr MJ, Mok PLH, Pedersen CB, Antonsen S, Ashcroft DM, Kapur N, Erlangsen A, Nordentoft M, Webb RT.

Soc Psychiatry Psychiatr Epidemiol. 2019 Oct 25. doi: 10.1007/s00127-019-01794-8. [Epub ahead of print]

PMID:
31654088
4.

Risk of major cardiovascular events in patients with psoriasis receiving biologic therapies: a prospective cohort study.

Rungapiromnan W, Mason KJ, Lunt M, McElhone K, Burden AD, Rutter MK, Warren RB, Griffiths CEM, Ashcroft DM; BADBIR Study Group.

J Eur Acad Dermatol Venereol. 2019 Oct 21. doi: 10.1111/jdv.16018. [Epub ahead of print]

PMID:
31633837
5.

Association of Psoriasis With the Risk of Developing or Dying of Cancer: A Systematic Review and Meta-analysis.

Trafford AM, Parisi R, Kontopantelis E, Griffiths CEM, Ashcroft DM.

JAMA Dermatol. 2019 Oct 16. doi: 10.1001/jamadermatol.2019.3056. [Epub ahead of print]

PMID:
31617868
6.

Current and potential contributions of community pharmacy teams to self-harm and suicide prevention: A qualitative interview study.

Gorton HC, Littlewood D, Lotfallah C, Spreadbury M, Wong KL, Gooding P, Ashcroft DM.

PLoS One. 2019 Sep 9;14(9):e0222132. doi: 10.1371/journal.pone.0222132. eCollection 2019.

7.

Modelling the interactive behaviour of users with a medication safety dashboard in a primary care setting.

Yera A, Muguerza J, Arbelaitz O, Perona I, Keers RN, Ashcroft DM, Williams R, Peek N, Jay C, Vigo M.

Int J Med Inform. 2019 Sep;129:395-403. doi: 10.1016/j.ijmedinf.2019.07.014. Epub 2019 Jul 23.

PMID:
31445283
8.

Process Mining in Primary Care: Avoiding Adverse Events Due to Hazardous Prescribing.

Williams R, Ashcroft DM, Brown B, Rojas E, Peek N, Johnson O.

Stud Health Technol Inform. 2019 Aug 21;264:447-451. doi: 10.3233/SHTI190261.

9.

Antibiotic choice in UK general practice: rates and drivers of potentially inappropriate antibiotic prescribing.

Nowakowska M, van Staa T, Mölter A, Ashcroft DM, Tsang JY, White A, Welfare W, Palin V.

J Antimicrob Chemother. 2019 Nov 1;74(11):3371-3378. doi: 10.1093/jac/dkz345.

PMID:
31430365
10.

Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review.

Alghamdi AA, Keers RN, Sutherland A, Ashcroft DM.

Drug Saf. 2019 Dec;42(12):1423-1436. doi: 10.1007/s40264-019-00856-9. Review.

11.
12.

Do population-level risk prediction models that use routinely collected health data reliably predict individual risks?

Li Y, Sperrin M, Belmonte M, Pate A, Ashcroft DM, van Staa TP.

Sci Rep. 2019 Aug 2;9(1):11222. doi: 10.1038/s41598-019-47712-5.

13.

The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort.

Nowakowska M, Zghebi SS, Ashcroft DM, Buchan I, Chew-Graham C, Holt T, Mallen C, Van Marwijk H, Peek N, Perera-Salazar R, Reeves D, Rutter MK, Weng SF, Qureshi N, Mamas MA, Kontopantelis E.

BMC Med. 2019 Jul 25;17(1):145. doi: 10.1186/s12916-019-1373-y.

14.

Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis.

Panagioti M, Khan K, Keers RN, Abuzour A, Phipps D, Kontopantelis E, Bower P, Campbell S, Haneef R, Avery AJ, Ashcroft DM.

BMJ. 2019 Jul 17;366:l4185. doi: 10.1136/bmj.l4185.

15.
16.

Incidence and prevalence of psoriasis in Israel between 2011 and 2017.

Schonmann Y, Ashcroft DM, Iskandar IYK, Parisi R, Sde-Or S, Comaneshter D, Batat E, Shani M, Vinker S, Griffiths CEM, Cohen AD.

J Eur Acad Dermatol Venereol. 2019 Nov;33(11):2075-2081. doi: 10.1111/jdv.15762. Epub 2019 Jul 11.

PMID:
31237370
17.

Prevalence, nature and risk factors for medication administration omissions in English NHS hospital inpatients: a retrospective multicentre study using Medication Safety Thermometer data.

Rostami P, Heal C, Harrison A, Parry G, Ashcroft DM, Tully MP.

BMJ Open. 2019 Jun 9;9(6):e028170. doi: 10.1136/bmjopen-2018-028170.

18.

Prevalence of maternal mental illness among children and adolescents in the UK between 2005 and 2017: a national retrospective cohort analysis.

Abel KM, Hope H, Swift E, Parisi R, Ashcroft DM, Kosidou K, Osam CS, Dalman C, Pierce M.

Lancet Public Health. 2019 Jun;4(6):e291-e300. doi: 10.1016/S2468-2667(19)30059-3.

19.

Prevalence of comorbid mental and physical illnesses and risks for self-harm and premature death among primary care patients diagnosed with fatigue syndromes.

Carr MJ, Ashcroft DM, White PD, Kapur N, Webb RT.

Psychol Med. 2019 May 27:1-8. doi: 10.1017/S0033291719001065. [Epub ahead of print]

PMID:
31131782
20.

Evaluating the implementation and impact of a pharmacy technician-supported medicines administration service designed to reduce omitted doses in hospitals: a qualitative study.

Seston EM, Ashcroft DM, Lamerton E, Harper L, Keers RN.

BMC Health Serv Res. 2019 May 22;19(1):325. doi: 10.1186/s12913-019-4146-6.

21.

Mapping the territory of renal care: a formative analysis of the cognitive work involved in managing acute kidney injury.

Phipps DL, Blakeman TM, Morris RL, Ashcroft DM.

Ergonomics. 2019 Sep;62(9):1117-1133. doi: 10.1080/00140139.2019.1620968. Epub 2019 Jun 11.

PMID:
31111790
22.

Antibiotic prescribing for common infections in UK general practice: variability and drivers.

Palin V, Mölter A, Belmonte M, Ashcroft DM, White A, Welfare W, van Staa T.

J Antimicrob Chemother. 2019 Aug 1;74(8):2440-2450. doi: 10.1093/jac/dkz163.

23.

Reducing risk following self-harm: the need for careful prescribing.

Chew-Graham CA, Morgan C, Webb RT, Emery A, Carr MJ, Kontopantelis E, Yung AR, Ashcroft DM.

Br J Gen Pract. 2019 May;69(682):224-225. doi: 10.3399/bjgp19X702317. No abstract available.

PMID:
31023669
24.

Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus.

Wright AK, Kontopantelis E, Emsley R, Buchan I, Mamas MA, Sattar N, Ashcroft DM, Rutter MK.

Circulation. 2019 Jun 11;139(24):2742-2753. doi: 10.1161/CIRCULATIONAHA.118.039100. Epub 2019 Apr 15.

PMID:
30986362
25.
26.

Capturing Patients' Perspectives on Medication Safety: The Development of a Patient-Centered Medication Safety Framework.

Giles SJ, Lewis PJ, Phipps DL, Mann F, Avery AJ, Ashcroft DM.

J Patient Saf. 2019 Mar 11. doi: 10.1097/PTS.0000000000000583. [Epub ahead of print]

PMID:
30882613
27.

Prevalence of mental illness in primary care and its association with deprivation and social fragmentation at the small-area level in England.

Grigoroglou C, Munford L, Webb RT, Kapur N, Ashcroft DM, Kontopantelis E.

Psychol Med. 2019 Feb 12:1-10. doi: 10.1017/S0033291719000023. [Epub ahead of print]

PMID:
30744718
28.

Exploring the human factors of prescribing errors in paediatric intensive care units.

Sutherland A, Ashcroft DM, Phipps DL.

Arch Dis Child. 2019 Jun;104(6):588-595. doi: 10.1136/archdischild-2018-315981. Epub 2019 Feb 8.

29.

Self harm attempt in the older population of the UK - Author's reply.

Morgan C, Chew-Graham CA, Kontopantelis E, Kapur N, Webb RT, Carr MJ, Ashcroft DM.

Lancet Psychiatry. 2019 Feb;6(2):92-93. doi: 10.1016/S2215-0366(19)30003-3. No abstract available.

PMID:
30686390
30.

Spatial distribution and temporal trends in social fragmentation in England, 2001-2011: a national study.

Grigoroglou C, Munford L, Webb RT, Kapur N, Ashcroft DM, Kontopantelis E.

BMJ Open. 2019 Jan 24;9(1):e025881. doi: 10.1136/bmjopen-2018-025881.

31.

Assessing the severity of Type 2 diabetes using clinical data-based measures: a systematic review.

Zghebi SS, Panagioti M, Rutter MK, Ashcroft DM, van Marwijk H, Salisbury C, Chew-Graham CA, Buchan I, Qureshi N, Peek N, Mallen C, Mamas M, Kontopantelis E.

Diabet Med. 2019 Jun;36(6):688-701. doi: 10.1111/dme.13905. Epub 2019 Feb 16. Review.

PMID:
30672017
32.

Investigating the Agreement Between Cardiovascular Disease Risk Calculators Among People Diagnosed With Schizophrenia.

Berry A, Drake RJ, Webb RT, Ashcroft DM, Carr MJ, Yung AR.

Front Psychiatry. 2018 Dec 12;9:685. doi: 10.3389/fpsyt.2018.00685. eCollection 2018.

33.

Persistence and effectiveness of nonbiologic systemic therapies for moderate-to-severe psoriasis in adults: a systematic review.

Mason KJ, Williams S, Yiu ZZN, McElhone K, Ashcroft DM, Kleyn CE, Jabbar-Lopez ZK, Owen CM, Reynolds NJ, Smith CH, Wilson N, Warren RB, Griffiths CEM.

Br J Dermatol. 2019 Aug;181(2):256-264. doi: 10.1111/bjd.17625. Epub 2019 Mar 27. Review.

34.

Relationship between prescribing of antibiotics and other medicines in primary care: a cross-sectional study.

Li Y, Mölter A, White A, Welfare W, Palin V, Belmonte M, Ashcroft DM, Sperrin M, van Staa TP.

Br J Gen Pract. 2019 Jan;69(678):e42-e51. doi: 10.3399/bjgp18X700457. Epub 2018 Dec 17.

35.

Development and validation of a multivariable risk prediction model for serious infection in patients with psoriasis receiving systemic therapy.

Yiu ZZN, Sorbe C, Lunt M, Rustenbach SJ, Kühl L, Augustin M, Mason KJ, Ashcroft DM, Griffiths CEM, Warren RB; BADBIR Study Group.

Br J Dermatol. 2019 Apr;180(4):894-901. doi: 10.1111/bjd.17421. Epub 2019 Jan 15.

36.

SMASH! The Salford medication safety dashboard.

Williams R, Keers R, Gude WT, Jeffries M, Davies C, Brown B, Kontopantelis E, Avery AJ, Ashcroft DM, Peek N.

J Innov Health Inform. 2018 Oct 18;25(3):183-193. doi: 10.14236/jhi.v25i3.1015.

37.

Disparities in mortality among 25-44-year-olds in England: a longitudinal, population-based study.

Kontopantelis E, Buchan I, Webb RT, Ashcroft DM, Mamas MA, Doran T.

Lancet Public Health. 2018 Dec;3(12):e567-e575. doi: 10.1016/S2468-2667(18)30177-4. Epub 2018 Oct 31. Erratum in: Lancet Public Health. 2018 Dec;3(12):e566.

38.

What causes medication administration errors in a mental health hospital? A qualitative study with nursing staff.

Keers RN, Plácido M, Bennett K, Clayton K, Brown P, Ashcroft DM.

PLoS One. 2018 Oct 26;13(10):e0206233. doi: 10.1371/journal.pone.0206233. eCollection 2018.

39.

Developing a learning health system: Insights from a qualitative process evaluation of a pharmacist-led electronic audit and feedback intervention to improve medication safety in primary care.

Jeffries M, Keers RN, Phipps DL, Williams R, Brown B, Avery AJ, Peek N, Ashcroft DM.

PLoS One. 2018 Oct 26;13(10):e0205419. doi: 10.1371/journal.pone.0205419. eCollection 2018.

40.

Risk factors for self-harm in people with epilepsy.

Gorton HC, Webb RT, Pickrell WO, Carr MJ, Ashcroft DM.

J Neurol. 2018 Dec;265(12):3009-3016. doi: 10.1007/s00415-018-9094-2. Epub 2018 Oct 24.

41.

Self-harm in a primary care cohort of older people: incidence, clinical management, and risk of suicide and other causes of death.

Morgan C, Webb RT, Carr MJ, Kontopantelis E, Chew-Graham CA, Kapur N, Ashcroft DM.

Lancet Psychiatry. 2018 Nov;5(11):905-912. doi: 10.1016/S2215-0366(18)30348-1. Epub 2018 Oct 15.

42.

Organizational conditions for engagement in quality and safety improvement: a longitudinal qualitative study of community pharmacies.

Phipps DL, Jones CEL, Parker D, Ashcroft DM.

BMC Health Serv Res. 2018 Oct 17;18(1):783. doi: 10.1186/s12913-018-3607-7.

43.

The challenge of ageing populations and patient frailty: can primary care adapt?

Reeves D, Pye S, Ashcroft DM, Clegg A, Kontopantelis E, Blakeman T, van Marwijk H.

BMJ. 2018 Aug 28;362:k3349. doi: 10.1136/bmj.k3349. No abstract available.

44.

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group.

Br J Dermatol. 2019 Feb;180(2):329-337. doi: 10.1111/bjd.17036. Epub 2018 Oct 21. Erratum in: Br J Dermatol. 2019 Sep;181(3):646.

PMID:
30070708
45.

Association between a national primary care pay-for-performance scheme and suicide rates in England: spatial cohort study.

Grigoroglou C, Munford L, Webb RT, Kapur N, Doran T, Ashcroft DM, Kontopantelis E.

Br J Psychiatry. 2018 Oct;213(4):600-608. doi: 10.1192/bjp.2018.143. Epub 2018 Jul 30.

PMID:
30058517
46.

Exploring medicines management by COPD patients and their social networks after hospital discharge.

Schafheutle EI, Fegan T, Ashcroft DM.

Int J Clin Pharm. 2018 Oct;40(5):1019-1029. doi: 10.1007/s11096-018-0688-7. Epub 2018 Jul 28.

47.

Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study.

Parisi R, Webb RT, Kleyn CE, Carr MJ, Kapur N, Griffiths CEM, Ashcroft DM.

Br J Dermatol. 2019 Jan;180(1):108-115. doi: 10.1111/bjd.17004. Epub 2018 Oct 10.

PMID:
30007069
48.

Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.

Zghebi SS, Rutter MK, Ashcroft DM, Salisbury C, Mallen C, Chew-Graham CA, Reeves D, van Marwijk H, Qureshi N, Weng S, Peek N, Planner C, Nowakowska M, Mamas M, Kontopantelis E.

BMJ Open. 2018 Jun 30;8(6):e020926. doi: 10.1136/bmjopen-2017-020926.

49.
50.

Understanding procedural violations using Safety-I and Safety-II: The case of community pharmacies.

Jones CEL, Phipps DL, Ashcroft DM.

Saf Sci. 2018 Jun;105:114-120. doi: 10.1016/j.ssci.2018.02.002.

Supplemental Content

Loading ...
Support Center